Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort
Condition: Treatment of Deep Vein Thrombosis and/or Pulmonary Embolism in Cancer Patients Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939); Drug: Low molecular weight heparin (LMWH); Drug: Direct Oral Anticoagulants (DOAC) Sponsor: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Pulmonary Thromboembolism | Research | Study | Thrombosis | USA Health